| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |